Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program

newsfileOct 4 07:30 ET

Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program

newsfileAug 28 07:30 ET

Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio

newsfileJul 22 17:00 ET

CSE Bulletin: Reinstatement - Awakn Life Sciences Corp. (AWKN)

newsfileMay 31 11:14 ET

CSE Bulletin: Suspensions - AWKN, BHCC, BZAM, GLOW, VTAL, JKPT, MEAL,VFI.X, STHZ

newsfileMay 8 10:45 ET

Awakn Life Sciences Discusses Filing of Financial Statements

newsfileMay 2 18:00 ET